Title: Correlating Serum Ceruloplasmin and Troponin I levels in patients diagnosed with acute myocardial infarction

Authors: Sweta Das, Anita R. Bijoor

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i11.189

Abstract

The current study was undertaken to assess the levels of serum ceruloplasmin (CP) in patients diagnosed with acute myocardial infarction (AMI) and to see if a correlation exists between serum CP which is an indicator of production of free radicals in the body and troponin I (Tn I)  which is an indicator of the severity of AMI. Serum CP, was estimated by manual method of Ravin (Copper Oxidase - enzymatic method). Serum CP levels in patients with AMI was raised. Serum Tn I levels were increased in patients with AMI. The levels of serum CP had a positive correlation with serum Tn I levels.

Keywords: Ceruloplasmin, Troponin I , Acute Myocardial Infarction.

References

  1. Christoph Liebetrau et al . Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay. BMC Medicine 2015 13:169.
  2. Reunanen A, Knekt P, Aaran RK. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol 1992; 136 (9): 1082-90.
  3. Simpson PJ et al. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med. 1987 Jul;110(1):13-30.
  4. HB Sirajwala, AS Dabhi et al. Serum Ceruloplasmin Level as an Extracellular Antioxidant in Acute Myocardial Infarction. JIACM 2007; 8(2): 135-8.
  5. Deepa M et al.  Free radicals and antioxidant status in acute myocardial infarction patients with and without diabetes mellitus. Bangladesh Med Res Counc Bull. 2009 Dec;35(3):95-100.
  6. Tietz NW, editor. Clinical guide to laboratory tests 3rd ed. Philadelphia: WB Saunders Company 1995.
  7. H. Wilson Tang, Yuping Wu et al. Clinical and Genetic Association of Serum Ceruloplasmin with Cardiovascular Risk Arterioscler Thromb Vasc Biol. 2012 February ; 32(2): 516–522. doi:10.1161/ATVBAHA.111.237040.
  8. Venkataramana, V.Krishnamurthy and V.Anjaneya Prasad . Serum copper and serum ceruloplasmin levels in acute myocarial infarction. Int J Pharm Bio Sci 2012 July; 3(3): (B) 456 – 461.
  9. Abdullah Kh. Ibrahem , Rana T. Mohsen, Nisreen M. Khalfl. Serum Bilirubin, Protein, and Ceruloplasmin in Acute Myocardial Infarction. IASJ Vol.6,No.1, September 2008 , ISSN: 2070-8882.
  10. Fox PL, Mukhopadhyay C, Ehrenwald E. Structure, oxidant activity, and cardiovas-cular mechanisms of human ceruloplasmin. Life Sci. 1995;56(21):1749–58.
  11. Neela Patil, Vishwas Chavan, N.D.Karnik. Antioxidant status in patients with acute myocardial infarction. Indian Journal of Clinical Biochemistry, 2007 / 22 (1) 45-51.
  12. P. T.Komala, Dr. S. Malliga , Dr.N.Muninathan. Study Of Antioxidant Status In Myocardial Infarction Cases Before And After Thrombolytic Therapy IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)e-ISSN: 2278-3008. Volume 5, Issue 4 (Mar. – Apr. 2013), PP 01-03.
  13. Bagatini MD, Martins CC, Battisti V, Gasparetto D, da Rosa CS, Spanevello RM, et al. Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels. 2011 Jan;26(1):55–63.
  14. Rains MG, Laney CA, Bailey AL, Campbell CL. Biomarkers of acute myocardial infarction in the elderly: troponin and beyond. Clin Interv Aging. 2014 Jul 11;9:1081–90.

Corresponding Author

Sweta Das

Department of Biochemistry, St. John’s Medical College, Bangalore, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.